Horizon Medical Products, Inc. Launches Innovative Line Enhancements.Business Editors ATLANTA--(BUSINESS WIRE)--April 6, 2004 Horizon Medical Products, Inc. (Amex: HMP HMP - hybrid multiprocessing ) today announced the launch of two new products within its family of Vortex(R) MP Ports and LifeGuard(TM) safety infusion needles - both engineered to further increase the performance levels and safety for the patient and caregiver. The first is an expansion of HMP's family of Vortex(R) MP ports to include the FluoroMax(TM) high-radiopacity silicone catheter option. The polyurethane version launched February 17, 2004. The small dimension of the Vortex(R) MP in the silicone configurations also adds a new option for the smaller patient community who prefer this catheter material for more delicate vasculature vasculature /vas·cu·la·ture/ (vas´ku-lah-chur) 1. circulatory system. 2. any part of the circulatory system. vas·cu·la·ture n. . The insertion kit will premier the new PeelPro(TM) ergonomic introducers, specialty Nitinol guidewires, and clear view packaging with an easy reference icon system. "These new features, combined with patented Vortex(R) technology, make this an exciting addition to the port line and is an ideal choice for chest or peripheral placements," stated Robert J. Wenzel, Horizon's President and Interim CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . HMP also announced an enhancement to their LifeGuard(TM) safety infusion needles with the addition of a valved needless access connector or NAC See network access control. . The incorporation of the new valve eliminates four previously required steps, which makes the LifeGuard(TM) significantly quicker and easier for clinicians to use than the previous version. This enhancement reduces the risk of air entering the system, resulting in an even safer product for the patient and caregiver. Kyle Coddington, product manager for HMP, commented, "The LifeGuard(TM) line of safety infusion needles has been successful since its debut in 2002. The addition of the LifeGuard(TM) NAC will help further strengthen our leadership position." Non-coring infusion needles are used to access implanted ports to infuse in·fuse v. 1. To steep or soak without boiling in order to extract soluble elements or active principles. 2. To introduce a solution into the body through a vein for therapeutic purposes. various medications, including chemotherapy. Proper use of the LifeGuard(TM) Safety Needle helps reduce the incidence of accidental needle sticks and subsequent blood borne pathogen exposure. Vortex(R) port systems incorporate a rounded chamber and off-set stem to promote more efficient flushing. The design has been clinically proven to significantly reduce complications, and is guaranteed against sludge buildup in the chamber of the port. ABOUT HORIZON MEDICAL PRODUCTS Horizon Medical Products, Inc. headquartered in Atlanta, is a world leader in design, development, manufacture and sale of technologically advanced, high value-added, percutaneous vascular and spinal access systems. The Company's oncology product lines include implantable ports, some of which feature its proprietary Vortex(R) technology; tunneled central venous catheters central venous catheter n. A catheter passed through a peripheral vein and ending in the thoracic vena cava; it is used to measure venous pressure or to infuse concentrated solutions. ; and stem-cell transplant catheters used primarily in cancer treatment protocols. The Company also markets a complete line of acute and chronic dialysis catheters. In June 2003, the Company gained exclusive U.S. rights to distribute Medtronic Inc.'s Hepatic Arterial Infusion (HAI HAI Health Action International HAI Healthcare-Associated Infections HAI Helicopter Association International HAI Hospital Acquired Infection HAI Hemagglutination Inhibition (Immune assay type, microbiology) ) product line, including sales and case support of Medtronic's IsoMed(R) Infusion System and related products. Its Internet address is www.hmpvascular.com. SAFE HARBOR Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Certain statements and information included herein may constitute "forward-looking statements" which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. The forward-looking statements are based on current expectations and may be significantly impacted by certain risks and uncertainties described herein and various documents filed by the Company with the U.S. Securities and Exchange Commission, including but not limited to the Company's Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. for the year ended December 31, 2003 and the Company's Quarterly Reports on Form 10-Q Form 10-Q See 10-Q. . There can be no assurances that statements made in this press release relating to future events will be achieved. The Company undertakes no obligations to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion